PTVE Crosses Above Average Analyst Target

Written by Emily J. Thompson, Senior Investment Analyst

PTVE%

Source: NASDAQ.COM

Updated: Apr 01 2025

0mins

Source: NASDAQ.COM

Stock Performance: Pactiv Evergreen Inc's shares have surpassed the average analyst 12-month target price of $18.00, currently trading at $18.02/share, prompting analysts to consider either downgrading their valuation or raising the target price based on the company's performance.
Analyst Insights: The average target price is derived from multiple analysts, with varying opinions; while some maintain a target of $18.00, others suggest higher potential, indicating that investors should evaluate whether the stock has room for growth or if it’s time to sell.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

PTVE Crosses Above Average Analyst Target

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

4D Molecular Therapeutics Grants 23,600 RSUs to New Employees

Tesla (TSLA) Nears Completion of AI5 Chip Design, AI6 Development Underway

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch